Skip to content
10-Q

Quarterly Report

INVIVO THERAPEUTICS HOLDINGS CORP.

0001558370-23-014294

← back to feed
Filed
Aug 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 3, 2023 3.11M sh
Shares Diluted Q2 2023 · Jun 30, 2023 2.92M sh
Shares Diluted Q2 2023 · Jun 30, 2022 1.38M sh
Capex Q2 2023 · Jun 30, 2023 $28K
Capex Q2 2023 · Jun 30, 2022 $82K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$5.66M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$5.92M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $10.72M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $16.35M
Stockholders Equity Q2 2023 · Jun 30, 2023 $11.58M
Stockholders Equity Q2 2023 · Mar 31, 2023 $13.48M
Stockholders Equity Q2 2023 · Dec 31, 2022 $15.75M
Stockholders Equity Q2 2023 · Jun 30, 2022 $12.81M
Stockholders Equity Q2 2023 · Mar 31, 2022 $15.52M
Stockholders Equity Q2 2023 · Dec 31, 2021 $18.12M
Current Liabilities Q2 2023 · Jun 30, 2023 $1.37M
Current Liabilities Q2 2023 · Dec 31, 2022 $2.42M
Total Liabilities Q2 2023 · Jun 30, 2023 $1.76M
Total Liabilities Q2 2023 · Dec 31, 2022 $3.08M
Current Assets Q2 2023 · Jun 30, 2023 $12.5M
Current Assets Q2 2023 · Dec 31, 2022 $17.6M
Total Assets Q2 2023 · Jun 30, 2023 $13.33M
Total Assets Q2 2023 · Dec 31, 2022 $18.82M
Eps Diluted Q2 2023 · Jun 30, 2023 −$1.46
Eps Diluted Q2 2023 · Jun 30, 2022 −$3.90
Eps Basic Q2 2023 · Jun 30, 2023 −$0.62
Eps Basic Q2 2023 · Jun 30, 2023 −$1.46
Eps Basic Q2 2023 · Jun 30, 2022 −$1.97
Eps Basic Q2 2023 · Jun 30, 2022 −$3.90
Sga Expense Q2 2023 · Jun 30, 2023 $1.37M
Sga Expense Q2 2023 · Jun 30, 2023 $2.48M
Sga Expense Q2 2023 · Jun 30, 2022 $1.38M
Sga Expense Q2 2023 · Jun 30, 2022 $2.62M
Rd Expense Q2 2023 · Jun 30, 2023 $715K
Rd Expense Q2 2023 · Jun 30, 2023 $2.1M
Rd Expense Q2 2023 · Jun 30, 2022 $1.35M
Rd Expense Q2 2023 · Jun 30, 2022 $2.78M
Net Income Q2 2023 · Jun 30, 2023 −$1.94M
Net Income Q2 2023 · Jun 30, 2023 −$4.27M
Net Income Q2 2023 · Mar 31, 2023 −$2.33M
Net Income Q2 2023 · Jun 30, 2022 −$2.72M
Net Income Q2 2023 · Jun 30, 2022 −$5.37M
Net Income Q2 2023 · Mar 31, 2022 −$2.66M
Operating Income Q2 2023 · Jun 30, 2023 −$2.09M
Operating Income Q2 2023 · Jun 30, 2023 −$4.57M
Operating Income Q2 2023 · Jun 30, 2022 −$2.73M
Operating Income Q2 2023 · Jun 30, 2022 −$5.4M